Açaí Berries Inhibit Colon Tumorigenesis in Azoxymethane/Dextran Sulfate Sodium-Treated Mice

Yoon Jin Choi1, Yoon Jeong Choi1, Nayoung Kim1,2

  • 1Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.

Gut and Liver
|December 15, 2016
PubMed
Abstract

Insights

Açaí supplementation significantly reduced colorectal cancer incidence and tumor development in mice. This fruit may offer protective benefits for preventing human colon cancer.

Area of Science:

  • Nutritional Science
  • Cancer Research
  • Gastroenterology

Background:

  • Colorectal cancer (CRC) poses a significant global health challenge.
  • Azoxymethane (AOM)/dextran sulfate sodium (DSS) models are widely used to study CRC development.
  • Investigating natural compounds for cancer prevention is crucial.

Purpose of the Study:

  • To evaluate the chemopreventive potential of açaí against AOM/DSS-induced colorectal cancer.
  • To elucidate the molecular mechanisms underlying açaí's protective effects.

Main Methods:

  • Açaí powder was administered to mice in a chemically induced colorectal cancer model.
  • Tumor incidence, multiplicity, and invasiveness were assessed.
  • Biomarkers of inflammation (MPO, TNF-α, IL-1β, IL-6) and cell proliferation/apoptosis (PCNA, Bcl-2, Bad, cleaved-caspase-3) were quantified.

Main Results:

  • Açaí administration significantly reduced adenoma and cancer incidence.
  • Açaí suppressed key inflammatory markers and downregulated proliferation markers.
  • Açaí promoted apoptosis by modulating Bcl-2 family proteins and caspase-3 activation.

Conclusions:

  • Açaí exhibits significant chemopreventive effects against colorectal cancer in a preclinical model.
  • Açaí's anti-cancer properties are mediated through the modulation of inflammatory pathways and apoptosis.
  • Dietary intake of açaí may contribute to the prevention of human colon cancer.

Related Concept Videos